Exact Sciences Corporation

EXAS

$67.15

Name : Exact Sciences Corporation

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $12,722,998,272.00

EPSttm : -5.35

Exact Sciences Corporation

$67.15

0.18%

$0.12

Float Short %

4.25

Margin Of Safety %

-32

Put/Call OI Ratio

1.02

EPS Next Q Diff

-0.16

EPS Last/This Y

6.02

EPS This/Next Y

0.68

Price

67.14

Target Price

83.65

Analyst Recom

1.44

Performance Q

Relative Volume

0.89

Beta

1.45

Ticker: EXAS

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	EXAS	62.73	0.99	0.72	36462
2025-10-21	EXAS	63.42	0.98	0.26	37315
2025-10-22	EXAS	62.9	0.97	0.54	37879
2025-10-23	EXAS	64.85	0.97	0.65	38107
2025-10-24	EXAS	64.64	0.97	0.32	38547
2025-10-27	EXAS	63.47	0.97	0.16	37606
2025-10-28	EXAS	63.31	0.98	0.54	37615
2025-10-29	EXAS	62.72	1.00	0.27	37530
2025-10-30	EXAS	63.22	1.00	0.22	37696
2025-10-31	EXAS	64.69	1.00	0.63	37780
2025-11-03	EXAS	66.99	1.01	0.49	36832
2025-11-04	EXAS	69.56	0.98	0.44	39381
2025-11-05	EXAS	69.61	1.03	0.43	40577
2025-11-06	EXAS	67.2	1.03	0.45	40934
2025-11-07	EXAS	66.18	1.03	0.53	41079
2025-11-10	EXAS	66.57	1.08	0.99	38431
2025-11-11	EXAS	67.33	1.09	0.32	38950
2025-11-12	EXAS	68.38	1.05	0.42	39361
2025-11-13	EXAS	67.76	1.06	0.20	39678
2025-11-14	EXAS	67.03	1.01	0.48	40783
2025-11-17	EXAS	67.14	1.02	0.37	39785
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	EXAS	62.73	226.5	1170.6	0.36
2025-10-21	EXAS	63.42	225.4	1168.4	0.37
2025-10-22	EXAS	62.91	225.4	1165.2	0.37
2025-10-23	EXAS	64.85	225.4	1171.7	0.37
2025-10-24	EXAS	64.65	225.4	1166.0	0.37
2025-10-27	EXAS	63.49	225.4	1163.5	0.37
2025-10-28	EXAS	63.30	225.4	1166.0	0.37
2025-10-29	EXAS	62.72	225.4	1165.0	0.37
2025-10-30	EXAS	63.22	225.4	1167.8	0.37
2025-10-31	EXAS	64.69	225.4	1170.4	0.37
2025-11-03	EXAS	66.99	225.4	1172.5	0.37
2025-11-04	EXAS	69.56	225.4	1173.0	0.37
2025-11-05	EXAS	69.63	225.4	1166.6	0.37
2025-11-06	EXAS	67.21	369.7	1135.5	0.38
2025-11-07	EXAS	66.18	369.7	1176.6	0.38
2025-11-10	EXAS	66.58	369.7	1181.0	0.38
2025-11-11	EXAS	67.50	389.6	1182.6	0.43
2025-11-12	EXAS	68.38	389.6	1182.4	0.43
2025-11-13	EXAS	67.78	389.6	1178.0	0.43
2025-11-14	EXAS	67.04	389.6	1177.6	0.43
2025-11-17	EXAS	67.14	389.6	1180.1	0.43
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	EXAS	-0.31	-5.76	3.60
2025-10-21	EXAS	-0.31	-5.76	3.60
2025-10-22	EXAS	-0.31	-5.76	3.60
2025-10-23	EXAS	-0.31	-5.76	3.60
2025-10-24	EXAS	-0.31	-5.76	3.60
2025-10-27	EXAS	-0.31	-6.13	4.27
2025-10-28	EXAS	-0.77	-6.13	4.27
2025-10-29	EXAS	-0.77	-6.13	4.27
2025-10-30	EXAS	-0.77	-6.13	4.27
2025-10-31	EXAS	-0.77	-6.13	4.27
2025-11-03	EXAS	-0.77	-7.10	4.27
2025-11-04	EXAS	-0.78	-7.10	4.27
2025-11-05	EXAS	-0.78	-7.10	4.27
2025-11-06	EXAS	-0.78	-7.10	4.26
2025-11-07	EXAS	-0.94	-7.10	4.26
2025-11-10	EXAS	-0.94	-7.08	4.26
2025-11-11	EXAS	-0.94	-7.08	4.26
2025-11-12	EXAS	-0.94	-7.08	4.25
2025-11-13	EXAS	-0.94	-7.08	4.25
2025-11-14	EXAS	-0.94	-7.08	4.25
2025-11-17	EXAS	-0.96	-5.79	4.25
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.24

Avg. EPS Est. Current Quarter

0.17

Avg. EPS Est. Next Quarter

0.08

Insider Transactions

-0.96

Institutional Transactions

-5.79

Beta

1.45

Average Sales Estimate Current Quarter

859

Average Sales Estimate Next Quarter

830

Fair Value

45.77

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

57.9

Max Drawdown 5-Year %

-80.4

Target Price

83.65

P/E

Forward P/E

219.57

PEG

P/S

4.13

P/B

5.09

P/Free Cash Flow

51.49

EPS

-5.32

Average EPS Est. Cur. Y

0.43

EPS Next Y. (Est.)

1.11

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-32.01

Relative Volume

0.89

Return on Equity vs Sector %

-66.4

Return on Equity vs Industry %

-50.4

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.06

EBIT Estimation

1180.1

Exact Sciences Corporation

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 6900

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Riskguard Test, a hereditary cancer test to understand their inherited risk of cancer. Its pipeline focus on advancing screening and diagnostic products, including risk assessment, screening and prevention, early disease diagnosis, adjuvant and/or neoadjuvant disease treatment, metastatic disease treatment selection, and recurrence monitoring. The company has license agreements with MAYO Foundation for Medical Education and Research and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

stock quote shares EXAS – Exact Sciences Corporation Stock Price stock today

news today EXAS – Exact Sciences Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch EXAS – Exact Sciences Corporation yahoo finance google finance

stock history EXAS – Exact Sciences Corporation invest stock market

stock prices EXAS premarket after hours

ticker EXAS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: EXAS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y